EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chromatin Remodeling of RasGRP3 Underlies Temozolomide Sensitivity in Glioblastoma Organoids

Bohan Chen, Guangsong Su, Yiting Huang, Rong Liu, Yingjie Song, Qian Xiao, Jie Lian, Chen Zhang, Yuhan Qiu, Qianlan Zhao, Jiayu Gu, Jian Zhong und 14 weitere

Advanced Science · 18.11.2026

DOI: 10.1002/advs.78665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 18.11.2026. Verfasst von Bohan Chen und 25 weiteren Autor:innen. Die Arbeit nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acquired resistance to temozolomide (TMZ) constitutes a formidable clinical barrier in the management of glioblastoma (GBM). GBM organoid models (GBO) that faithfully mirror the parental tumor phenotype serve as powerful research instruments to overcome the limitations in this field. We established GBOs derived from primary glioma patients and their TMZ low‐sensitivity counterparts. To unravel the intricate molecular underpinnings of this process, we performed an unbiased, integrated multi‐omics analysis encompassing epigenomic, 3D genomic, and transcriptomic profiling, coupled with dual CRISPR interference (CRISPRi) screening of TMZ‐induced enhancers (TiEns) and their cognate target genes. Our findings demonstrate that enhancer‐mediated 3D chromatin remodeling drives chemosensitivity predominantly by transcriptionally activating drug‐sensitivity‐associated genes, such as RasGRP3, VEGFA, BTN3A2 , etc. Knockdown or knockout of these genes and enhancers renders glioma cells more sensitive to TMZ, especially RasGRP3 . Our work unveils a druggable “enhancer‐chromatin‐target” signaling axis and proposes a novel combinatorial therapeutic strategy to surmount TMZ low sensitivity in GBM.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, B., Su, G., Huang, Y., Liu, R., Song, Y., Xiao, Q., Lian, J., Zhang, C., Qiu, Y., Zhao, Q., Gu, J., Zhong, J., Gao, Y., Wu, X., Ma, Y., Zheng, Y., Zhang, M., He, A., Bi, J., …, & Zhang, N. (2026). Chromatin Remodeling of RasGRP3 Underlies Temozolomide Sensitivity in Glioblastoma Organoids. Advanced Science. https://doi.org/10.1002/advs.78665

Vancouver

Chen B, Su G, Huang Y, Liu R, Song Y, Xiao Q, et al. Chromatin Remodeling of RasGRP3 Underlies Temozolomide Sensitivity in Glioblastoma Organoids. Advanced Science. 2026. doi:10.1002/advs.78665

BibTeX
@article{Chen2026,
  author = {Chen, Bohan and Su, Guangsong and Huang, Yiting and Liu, Rong and Song, Yingjie and Xiao, Qian and Lian, Jie and Zhang, Chen and Qiu, Yuhan and Zhao, Qianlan and Gu, Jiayu and Zhong, Jian and Gao, Yixin and Wu, Xujia and Ma, Yiping and Zheng, Yaoqiang and Zhang, Meng and He, Anshun and Bi, Jinfang and Li, Peng and Zhao, Zhongfang and Shi, Jiandang and Zhang, Lei and Huang, Bin and Lu, Wange and Zhang, Nu},
  title = {Chromatin Remodeling of RasGRP3 Underlies Temozolomide Sensitivity in Glioblastoma Organoids},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.78665}
}
Kostenlos starten →